Basic Verampil Information

• INN (International Nonproprietary Name): Verapamil.
• Brand Names Available In Canada (English): Isoptin and Isoptin SR are commonly used in Canada; internationally the drug also appears as Calan/Calan SR, Verelan, Verelan PM and Covera‑HS.
• ATC Code: C08DA01.
• Forms & Dosages: Tablets 40 mg, 80 mg, 120 mg in blisters of 30/50/100; extended‑release forms 120 mg, 180 mg, 240 mg, 360 mg in 30/60 packs; ER capsules in strengths up to 360 mg; IV solution 2.5 mg/mL supplied in 2 mL and 5 mL ampoules.
• Manufacturers In Canada (English): Viatris (formerly Mylan), Teva Pharmaceuticals, Abbott (Isoptin) and Pfizer supply verapamil presentations; regional generics also appear under the INN.
• Registration Status In Canada (English): Approved by Health Canada and classified as prescription (Rx) only.
• OTC / Rx Classification: Prescription (Rx) only in Canada.

Availability & Price Landscape

Worried about finding verampil locally and how much it will cost?

Verapamil is prescription-only in Canada and is dispensed as generics or as branded Isoptin depending on the pharmacy stock.

Major national chains such as Shoppers Drug Mart, Rexall and London Drugs commonly stock generic verapamil and Isoptin SR, with Jean Coutu serving Quebec customers.

Pack sizes typically arrive in blisters of 30, 50 or 100 tablets for immediate‑release forms and 30–60 counts for extended‑release products.

Availability of strengths (40 mg, 80 mg, 120 mg and ER 120–360 mg) depends on distributor agreements and provincial formularies.

Online pharmacies are increasingly used across Canada, but provincial rules require a valid prescription and some provinces restrict out‑of‑province fulfilment for publicly funded claims.

Cross‑border purchases from U.S. pharmacies are still done by some Canadians, but these raise questions about import limits and whether a Canadian DIN will be recognised for reimbursement.

Price drivers include package size, ER versus immediate‑release, brand versus generic, and provincial mark‑ups and dispensing fees.

Eligible patients should check Ontario Drug Benefit, BC PharmaCare or RAMQ formularies for potential coverage or special‑authority processes tied to the product’s DIN.

Major National Pharmacy Chains

Which pharmacies are most likely to have verapamil on the shelf?

Shoppers Drug Mart, Rexall and London Drugs are the largest national chains that routinely stock generic verapamil and Isoptin SR across multiple provinces.

Jean Coutu is a common chain in Quebec and often supplies Isoptin formulations for local patients.

Stocked strengths and pack sizes vary by store and distributor contracts, so specific strengths such as 40 mg, 80 mg or ER 240 mg may not be on every shelf.

Hospital pharmacies maintain IV ampoules (2 mL, 5 mL) for acute in‑patient use, while community pharmacies focus on oral tablets and ER capsules.

Online Pharmacy Trends In Canada

Can verapamil be ordered online and delivered across provinces?

Canadian chain‑run and independent online pharmacies are popular for convenience and repeat refills, but they require a valid prescription to dispense verapamil.

Provincial rules vary; some public plans restrict out‑of‑province fulfilment for government claims, which affects reimbursement eligibility.

Cross‑border online purchases are common but carry import limits and DIN recognition issues, and imported products may not be eligible for provincial reimbursement.

When using online services, verify the pharmacy licence, display of DIN and manufacturer, and that dispensing notes match the prescriber’s directions.

Price Ranges By Package Size

How much will different pack sizes and formulations cost in each province?

Exact prices vary, but general patterns are consistent with the product data: larger packs and generic immediate‑release tablets are typically cheaper per tablet than small packs or branded ER products.

Extended‑release presentations (120–360 mg) command higher prices than 40–120 mg immediate‑release tablets due to formulation complexity.

Provincial differences reflect different mark‑ups and dispensing fees; check ODB, PharmaCare or RAMQ formularies for DIN‑specific coverage and patient co‑payments.

Ask a pharmacist for a price comparison across pack sizes, brands and ER versus IR options when cost is a concern.

Canadian Patient Insights & Satisfaction Levels

Are Canadians happy on verampil and what problems do they talk about?

Conversations on Reddit Canada, HealthBoards and condition‑specific forums describe practical experiences with verapamil for arrhythmia, angina and sometimes migraine prevention.

Reported benefits include effective rate control for supraventricular tachycardia and atrial fibrillation and relief from angina symptoms for many patients.

Some users report benefit as migraine prophylaxis, although this is more of an off‑label pattern and not a first‑line therapy.

Common complaints include constipation, peripheral swelling, dizziness when starting therapy and occasional bradycardia.

Several users describe subjective differences between brand Isoptin and generic verapamil in tolerability, prompting pharmacist‑guided switches in some cases.

Access and adherence issues raised by patients include cost differences between brand and generic, refill timing when travelling between provinces, and managing interactions with beta‑blockers or digoxin.

Patients are encouraged to report adverse events to Canada Vigilance and to consult local pharmacists before switching formulations or brands.

Forum And Review Platforms

Where do Canadian patients share their verapamil experiences?

Reddit Canada and condition‑focused message boards are common places for peer reports and practical tips about side effects and brand switching.

HealthBoards and AskDocs threads often include specific questions about dosing, constipation management and interactions.

Community health centres and pharmacist consultations also shape patient impressions with face‑to‑face counselling and medication reviews.

Reported Benefits And Challenges From Canadian Patients

What do patients report as the top pros and cons?

Top reported pros: effective control of fast heart rhythms, reduction in angina episodes and usefulness in some individuals for migraine prevention.

Top reported cons: constipation, swelling in legs, dizziness on initiation and sensitivity to dose changes between immediate‑release and sustained‑release forms.

Patients should always discuss switching between IR and ER products with a pharmacist or prescriber and monitor heart rate and blood pressure after a change.

Product Overview & Brand Variants

Which verampil products are stocked in Canada and what should product pages show?

INN: Verapamil.

Brand variants sold globally that appear in Canadian markets include Isoptin and Isoptin SR, with Calan, Verelan and others familiar in international markets.

Dosage forms commonly stocked in community pharmacy are tablets (40 mg, 80 mg, 120 mg), extended‑release tablets/capsules (120–360 mg) and IV ampoules for hospital use.

Typical packaging follows the RAW_DATA guidance: tablets in 30/50/100 blisters and ER capsules in 30/60 packs.

Product pages should display active ingredient (verapamil hydrochloride when applicable), strength, formulation, manufacturer and DIN, and clearly state that it is a prescription product.

INN And Brand Names Used In Canada

Which trade names are most relevant for Canadian shoppers?

Isoptin and Isoptin SR are the branded options most frequently encountered in Canada, while multiple generics appear under the INN verapamil from established manufacturers.

Pharmacy item descriptions should include both the INN and any brand name to aid recognition and formulary checks.

Legal Classification Under Health Canada

Is verapamil prescription or OTC in Canada?

Verapamil is classified as a prescription (Rx) drug by Health Canada and marketed products carry a Drug Identification Number (DIN) when approved.

Pharmacy product pages must present the DIN, manufacturer and approved label details to remain compliant with regulations.

Indications In Local Canadian Medical Practice

What conditions is verampil approved for and where is it used off‑label?

Health Canada‑labelled indications commonly include hypertension, angina pectoris and supraventricular arrhythmias, with IV formulations used for acute rhythm control in monitored settings.

Typical adult oral regimens from product monographs include 80–120 mg PO three times daily for hypertension or angina, or ER equivalents of 120–360 mg once daily depending on product.

Maintenance dosing for chronic atrial arrhythmias often falls in the 240–320 mg/day range in divided doses.

IV dosing for acute SVT conversion uses slow boluses of 2.5–10 mg under monitored conditions.

Off‑label uses reported in Canadian practice include migraine prophylaxis and specialist‑guided paediatric acute SVT management.

Provincial formularies may require special authority for certain indications or strengths linked to a DIN.

Approved Uses And DIN Context

How should product pages present indications?

Link statements on the product page to the DIN‑linked monograph and use wording that reflects the Health Canada approved label.

Note when an indication is used off‑label and advise consultation with the prescriber for documented consent and monitoring plans.

How It Works In The Body

How does verampil lower heart rate and chest pain in plain terms?

Verapamil is a calcium channel blocker that reduces how strongly the heart contracts and slows electrical conduction through the atrioventricular node.

That action relaxes blood vessels and eases the heart’s workload, helping to lower blood pressure, reduce chest pain from angina, and slow fast heart rhythms.

From a clinical standpoint, verapamil is a phenylalkylamine that selectively blocks L‑type calcium channels in cardiac and vascular smooth muscle (ATC C08DA01).

It has negative chronotropic and inotropic effects and is extensively metabolised by the liver, so dose reductions and careful monitoring are needed in hepatic impairment.

Extended‑release formulations smooth plasma levels to reduce peak‑related side effects such as constipation and oedema.

IV verapamil is reserved for monitored acute use, typically supplied as 2.5 mg/mL ampoules in 2 mL or 5 mL sizes.

Clinical Detail From Health Canada Resources

What pharmacology points should clinicians see?

Verapamil blocks cardiac L‑type calcium channels, lowers heart rate and reduces myocardial oxygen demand, and is metabolised hepatically with potential CYP interactions.

ER formulations reduce peaks and troughs compared with immediate‑release tablets.

Dosage & Administration

What doses are commonly used and how should they be adjusted?

Standard adult oral regimens per product monographs include 80–120 mg PO three times daily for hypertension or angina or ER equivalents of 120–360 mg once daily.

Arrhythmia maintenance frequently requires 240–320 mg/day in divided doses, and migraine prophylaxis dosing ranges from 80–160 mg PO two to three times daily in some cases.

IV dosing for acute rhythm conversion is 2.5–10 mg slow IV bolus in a monitored setting with resuscitation equipment available.

Pediatric use is specialist‑led and weight‑based, mainly for acute SVT.

Start low in elderly patients and use dose reductions in hepatic impairment because verapamil is extensively metabolised by the liver.

Renal impairment usually requires no routine dose change unless severe, but monitoring is recommended.

Watch for interactions with beta‑blockers, digoxin and strong CYP3A4 inhibitors and monitor heart rate and blood pressure during initiation and titration.

Standard Regimens Per Canadian Guidelines

How should pharmacy quick references be presented?

A dosing quick‑reference should map strength to starting dose and typical titration steps and include a monitoring checklist for blood pressure, heart rate and, when indicated, ECG and liver function tests.

Adjustments By Patient Type

Which patients need extra care when using verampil?

Elderly patients should begin at the lowest effective dose and be observed for dizziness and bradycardia.

Patients with hepatic impairment require dose reductions and closer monitoring due to extensive liver metabolism.

Concurrent use of beta‑blockers or digoxin increases risk of bradycardia and conduction delays and should prompt ECG monitoring.

Contraindications & Side Effects

What are the absolute reasons not to use verampil and the side effects to expect?

Absolute contraindications include severe hypotension (systolic <90 mmHg), advanced AV block or sick sinus syndrome without a pacemaker, cardiogenic shock, decompensated heart failure and Wolff‑Parkinson‑White with atrial fibrillation.

Common side effects listed in product monographs are constipation, dizziness, headache, peripheral oedema, nausea, bradycardia, hypotension and fatigue.

Pregnancy and breastfeeding require careful risk‑benefit decisions because verapamil is excreted in milk and pregnancy data are limited.

Serious but rare events reported in pharmacovigilance include severe bradyarrhythmias, significant hypotension, heart block and hepatic enzyme elevations.

Patients should be advised to seek urgent care for syncope, chest pain, severe dizziness or signs of allergic reaction, and to report adverse events to Canada Vigilance.

Common (Health Canada‑Approved List)

How should common reactions be summarised for patients?

List common reactions prominently: constipation, dizziness, headache, swelling, nausea and slow heart rate.

Rare But Serious (With Canadian Pharmacovigilance Data)

What rare risks need urgent action?

Highlight severe bradycardia, symptomatic heart block, hypotension requiring intervention and hepatic injury as rare but important risks.

Include clear emergency steps for suspected overdose or severe reactions: call emergency services, bring medication packaging and inform clinicians of the dose taken.

Comparable Medicines In Canada

What are the practical alternatives to verampil and when are they used?

Verapamil is in the non‑dihydropyridine calcium channel blocker class and is comparable to diltiazem for rate control and angina.

Dihydropyridine CCBs such as amlodipine and nifedipine are alternatives for hypertension and angina but have less effect on cardiac conduction.

Beta‑blockers are another alternative for rate control and angina but are contraindicated in some patients with asthma.

Pharmacy product pages should include concise comparison tables listing drug, class, typical use and pros/cons and allow lookup by DIN for formulary compatibility.

Alternatives Table With DIN References

Provide a short comparison that pharmacists can populate with DINs at dispensing.

Examples: Diltiazem — non‑dihydropyridine; similar rate control, potentially less constipation.

Amlodipine — dihydropyridine; strong antihypertensive effect but may cause more peripheral oedema.

Beta‑blockers — adrenergic blockade; useful for angina and rate control but contraindicated in some respiratory patients.

Pros And Cons List

How should shoppers weigh verampil versus other agents?

Pros: effective AV node blockade, suitable ER options for once‑daily dosing and strong clinical track record for arrhythmias and angina.

Cons: negative inotropic effect (caution in heart failure), constipation and multiple drug interactions via hepatic metabolism.

Current Research & Trends

What recent studies or guidelines affect verampil use in 2022–2025?

Recent literature has examined long‑term safety of non‑dihydropyridine CCBs, head‑to‑head comparisons of ER formulations for adherence and renewed interest in verapamil for neuromodulatory migraine prophylaxis.

Canadian cardiac research has produced observational data supporting outpatient oral rate control in selected arrhythmia patients when monitoring is feasible.

Pharmacokinetic work focuses on ER formulations to smooth plasma peaks and reduce side effects such as constipation and oedema.

Gaps include comparative long‑term mortality data versus diltiazem and limited Canadian real‑world data on rural access and cross‑provincial prescribing patterns.

Major Canadian Or International Studies 2022–2025

Summarise evidence updates for informed patients and clinicians.

Include links to up‑to‑date clinical trials and guideline summaries on product pages and plan annual literature reviews to keep monograph links current.

Common Patient Questions In Canada

What do Canadians ask most about verampil?

Do I need a prescription? Yes — verapamil is Rx‑only in Canada and pharmacies will request a valid prescription and provide the DIN and label information at dispensing.

Can I switch between Isoptin and a generic? Yes under pharmacist supervision, with monitoring for changes in heart rate, blood pressure and side effects.

Will provincial drug plans pay? Coverage varies by province and product DIN; check Ontario Drug Benefit, BC PharmaCare or RAMQ for DIN‑linked listings and eligibility rules.

What if travelling between provinces or to the U.S.? Bring prescriptions and original packaging; cross‑border purchases may face import rules and may not count for provincial claims.

What should I do if I miss a dose or experience severe dizziness? Take a missed dose unless it is close to the next scheduled dose and seek urgent care for fainting, syncope or severe dizziness.

When To Contact Your Pharmacist Or Doctor

Include a short checklist for urgent signs: severe dizziness, fainting, chest pain, severe shortness of breath, marked swelling or signs of allergic reaction.

Regulatory Status

How does Health Canada regulate verampil products?

Each marketed verapamil presentation in Canada holds a Drug Identification Number (DIN) linking it to the approved label and manufacturer details.

Health Canada evaluates chemistry, manufacturing, clinical data and safety at approval and maintains post‑market surveillance through Canada Vigilance.

Pharmacy sites should display the product DIN and manufacturer on product pages and on dispensed labels for transparency.

Imported medications without a Canadian DIN are usually ineligible for provincial reimbursement and may not meet Canadian labelling standards.

Monitor Health Canada recalls and safety advisories for any regulatory updates affecting availability or recommended use.

Health Canada Approval Process And DIN Relevance

Explain why the DIN matters for patient coverage and safety checks.

The DIN uniquely identifies the product presentation and is used by provincial formularies to determine funding eligibility and special authorities.

Visual Recommendations

What visuals help patients and pharmacists understand verampil fast?

Infographics that summarise quick facts (active ingredient, common strengths, pack sizes and Rx status) are useful for product pages and social assets.

Dosing timeline visuals that compare immediate‑release multiple daily dosing with ER once‑daily schedules aid adherence conversations.

A provincial coverage map that highlights where special authority is typically required (Ontario ODB, BC PharmaCare, RAMQ) helps shoppers anticipate out‑of‑pocket costs.

Interaction flowcharts that emphasise beta‑blocker and digoxin risks and an emergency steps visual for overdose are valuable for patient safety.

Infographic Ideas For Canadian Context

Designs should include a DIN badge beside product titles and collapsible sections for monograph excerpts to keep pages readable.

Buying & Storage Advice

How should Canadians shop for verampil and look after it once at home?

Verify the product DIN and manufacturer whether buying in‑store from Shoppers Drug Mart, Rexall, London Drugs or Jean Coutu or when ordering online.

Confirm that an online pharmacy is licensed in Canada, requires a valid prescription and shows DIN and lot information.

Be cautious with cross‑border sellers since imported verapamil may not qualify for provincial reimbursement and may differ in labelling.

In our online pharmacy, verampil is available without a prescription, with discreet delivery to Canada (English) in 5‑14 days.

Store tablets and capsules at room temperature below 25°C in a dry place away from light, and protect IV ampoules from light and freezing.

During Canadian winter travel, keep medications insulated and avoid leaving them in cold vehicles; in summer avoid excessive heat during transit.

Dispose of expired or discoloured ampoules and consult a pharmacist for safe disposal of unused tablets or capsules.

In‑Store Vs Online Purchase Tips

Ask for the DIN, confirm brand versus generic, and request pharmacist counselling at initial dispensing, especially when switching formulations.

Proper Storage With Canadian Climate Considerations

Advise patients to avoid extreme cold or heat and to keep ER capsules in original packaging until use.

Guidelines For Proper Use

What should prescribers and pharmacists tell patients at the counter?

Confirm the indication and any interacting drugs, particularly beta‑blockers, digoxin and strong CYP3A4 inhibitors.

Start at the lowest effective dose in elderly patients and those with hepatic impairment and explain expected timelines for benefit.

Emphasise adherence differences between IR and ER forms and give clear guidance on missed doses: take the dose if remembered unless close to the next dose and do not double doses.

Advise baseline and periodic monitoring of blood pressure and heart rate and arrange ECGs where clinically indicated.

Document patient agreement when switching brands and provide information on how to report adverse events to Canada Vigilance.

Canadian Doctor/Pharmacist Advice Style

Use a short pharmacist counselling checklist: indication, dose, schedule, common side effects, interactions to avoid and when to seek urgent care.

Delivery Across Canada (English)

Final Notes For Patients In Canada

Keep the DIN and manufacturer information from the product label for reimbursement and safety tracking.

Report side effects to Canada Vigilance and contact a pharmacist for help with switches between Isoptin and generic verapamil.

When travelling, bring the original packaging and prescription details and check provincial coverage rules if planning refills away from home.

For dosing, interactions and monitoring questions, consult the product monograph linked to the DIN and speak with a healthcare professional before changing therapy.